Morepen Laboratories LimitedNSE: MOREPENLAB

Press Release Apr 01 2025

· Issued by Morepen Laboratories Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Morepen Laboratories Limited has announced that it has received approval for Loratadine export to China, marking a significant milestone in its strategic expansion into the Chinese pharmaceutical market. The approval from China's National Medical Products Administration reinforces Morepen's position as a leading global manufacturer of Loratadine, a widely used anti-allergy drug. Morepen commands a substantial market share in the US generics market for Loratadine and aims to capture a significant share of the Chinese market with this development.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Morepen Laboratories Limited on 6ix

Earlier from Morepen Laboratories

Later from Morepen Laboratories

All Morepen Laboratories news releases